CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Complications

Oncology NEWS International. Vol. 15 No. 11
Focus on Supportive Care 

Chlorhexadine Rinse Prevents Chemo-Induced Mucositis

November 1, 2006

ISTANBUL, Turkey—The frequency and duration of chemotherapy-induced oral mucositis may be significantly improved by either prophylactic chlorhexidine(Drug information on chlorhexidine) or by cryotherapy, according to the results of a randomized, double-blind, placebo-controlled study presented at the 31st Congress of the European Society for Medical Oncology (ESMO) (abstract 988 O).

Cryotherapy consists of ice chips swished around in the mouth during chemotherapy. This diminishes the amount of chemotherapy that reaches the oral mucosa if the chemotherapy is cleared from the blood before the cryotherapy stops. “Cryotherapy is easy and inexpensive,” said lead investigator Jens B. Sorensen, MD, of the National University Hospital, Copenhagen, Denmark, “but is drug- and schedule-dependent as it cannot be used with infusional fluorouracil(Drug information on fluorouracil) [5-FU] or with chemotherapy that has a substantially longer half-life than 5-FU.”

Chlorhexidine mouthwash has had mixed results in previous studies. Dr. Sorensen said that “this uncertainty may partly be due to the various clinical scenarios in which it has been tested.” To clarify the situation, the Danish researchers studied the value of chlorhexidine and cryotherapy only in the preventive setting, in patients with gastrointestinal cancer who were being treated with intravenous bolus 5-FU 425 mg/m2 and leucovorin 20 mg/m2 daily over 5 days. Each of 225 patients was randomly assigned to either chlorhexidine 0.1% 15 mL mouth rinse for 1 minute three times daily for 3 weeks, or normal saline with the same taste additive as in the chlorhexidine group, or to cryotherapy with crushed ice, 10 minutes before to 35 minutes after chemotherapy.

Of the 206 patients who answered a questionnaire, 13% of the chlorhexidine group, 33% of placebo patients, and 11% of cryotherapy patients said they had mucositis that was bad enough to impair eating or require artificial nutrition. The median duration of mucositis was 3 days with chlorhexidine, 5 days with placebo, and 1 day with cryotherapy.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 

 
PUBLICATIONS
ONCOLOGY Journal ONCOLOGY Nurse Edition Journal Cancer Management: A Multidisciplinary Approach

ONCOLOGY

ONCOLOGY:
Nurse Edition

CANCER
MANAGEMENT
:
A Multidisciplinary
Approach


 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • Bladder Cancer Recurrence High, Better Follow-Up Care Needed
  • ASCO: Post-Surgery Surveillance Found Safe in Seminoma
  • Fertility Preservation in Women With Breast Cancer: Challenges and Opportunities
  • Addressing Fertility Concerns in Women Diagnosed With Breast Cancer: Will Serial Reserve Screening Help?
  • Postmenopausal Hormone Receptor–Positive Advanced Breast Cancer
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Preventing Exposure to Hazardous Drugs
  • ASCO: Vinegar Screening Significantly Reduces Cervical Cancer Mortality
  • ASCO: Sulforaphane in Prostate Cancer Found Worthy of Further Investigation
  • Study: Recurrent Heartburn Ups Risk for Throat Cancer
  • HER2-Directed Therapy for Metastatic Breast Cancer
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • It’s Time for Clinicians to Reconsider Their Proscription Against the Use of Soyfoods by Breast Cancer Patients
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • ASCO: No Benefit From Avastin in Newly Diagnosed Glioblastoma
Click here to subscribe to our newsletter



CancerNetwork on Facebook
 
SearchMedica SEARCH RESULTS

Find peer-reviewed literature and websites for practicing medical professionals

CME on Oncologic Complications
Evidence on Oncologic Complications
Guidelines on Oncologic Complications
Patient Education on Oncologic Complications
Clinical Trials on Oncologic Complications
Practical Articles on Oncologic Complications
Research and Reviews on Oncologic Complications
All "Oncologic Complications" results

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy